Reversibility of left ventricular dysfunction in elderly patients with dilated cardiomyopathy by carvedilol. A case report;Reversibilità della disfunzione ventricolare sinistra nell'anziano affetto da cardiomiopatia dilatativa sottoposto a trattamento con carvedilolo. Descrizione di un caso

Italian Heart Journal Supplement

Volumn 2, Issue 6, 2001, Pages 668-672

  Cioffi, G ^a   Stefenelli, C ^a  

^a Reparto di Cardiologia   (Italy)

Author keywords

Carvedilol; Congestive heart failure; Dilated cardiomyopathy; Left ventricular systolic dysfunction; Older age

Indexed keywords

CARVEDILOL;

AGED; ARTICLE; CASE REPORT; CONGESTIVE HEART FAILURE; DRUG EFFICACY; HEART DILATATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MALE; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; CARBAZOLES; CARDIOMYOPATHY, DILATED; HUMANS; MALE; PROPANOLAMINES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034912085     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Introducing new treatments in clinical practice: The Italian approach to beta-blockers in heart failure
2. La storia dello studio SET-UP (ovvero come è difficile la neutralità nella ricerca clinica)
3. Estimation of pulmonary wedge pressure by transmitral Doppler in patients with chronic heart failure and atrial fibrillation
4. Doppler echocardiographic estimation of pulmonary artery wedge pressure in patients with chronic heart failure and atrial fibrillation
5. Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure
6. Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-area heart failure
7. Beta-blockade therapy in chronic heart failure: Diastolic function and mitral regurgitation improvement by carvedilol
8. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure
9. Is myocardial impairment in idiopathic dilated hypertrophic cardiomyopathy reversible by carvedilol? A case report
10. Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy
11. Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: Double-blind, randomised, placebo-controlled study
12. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure
13. Experience of commencing carvedilol in elderly patients with heart failure in a routine outpatient clinic
14. Pharmacokinetics of carvedilol in older and younger patients
15. Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure
16. Metoprolol in dilated cardiomyopathy: Is it possible to identify factors predictive of improvement?
17. Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint
18. Which patients with chronic heart failure are most likely to show hemodynamic and functional improvement following long-term beta-blockade?